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ABSTRACT
Objective: To evaluate shoulder functional results and the 
retear rate of arthroscopic repair of the rotator cuff augmented 
with platelet-rich plasma (PRP).Methods: Prospective case series 
with single-row arthroscopic repair of the rotator cuff augmen-
ted with PRP. Only cases of isolated supraspinatus tears with 
retraction of less than 3 cm were included in this series. The 
PRP used was obtained by apheresis. It was applied on liquid 
consistency in its activated form, with the addition of autologous 
thrombin. Patients were evaluated after 12 months of the surgical 
procedure. The Constant-Murley, UCLA and VAS scales were 
used, and the retear rate was assessed using magnetic resonance 
imaging (MRI). Results: Fourteen patients were evaluated (14 
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shoulders). The mean Constant-Murley score was 45.64 ± 12.29 
before the operation and evolved to 80.78 ± 13.22 after the ope-
ration (p < 0.001). The UCLA score increased from 13.78 ± 5.66 
to 31.43 ± 3.9 (p < 0.001). The patients’ pain level decreased 
from a median of 7.5 (p25% = 6, p75% = 8) to 0.5 (p25% = 0, 
p75% = 3) (p = 0.0013) according to the VAS score. None of 
the patients presented complete retear. Three patients (21.4%) 
showed partial retear, without transfixation. Only one patient 
developed complications (adhesive capsulitis). Conclusion: Pa-
tients submitted to  arthroscopic rotator cuff repair augmented 
with PRP showed significant functional improvement and none 
of them had complete retearing.
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INTRODUCTION
Tears of the rotator cuff have a high prevalence in 
the general population(1). Despite satisfactory clinical 
results with arthroscopic repair of the rotator cuff (ar-
throRRC)(2-4), the index of rerupture is high, ranging 
from 10 to 95%(2-6).
Deficient healing between the tendon and bone 
is believed to be the main cause of reruptures. Bio-
logical strategies that improve the process of heal-
ing between tendon and bone in rotator cuff repair 
(RCR) are currently being sought(7-10), with emphasis 
on the action of growth factors (GF). The platelet-rich 
plasma (PRP) is a fraction of plasma with platelet 
concentrations above baseline levels obtained autolo-
gously(11), and rich in GF that are important during the 
healing process(12).
In orthopedics, the effects of PRP on the knee(13,14), 
in the spinal column(15), in elbow tendinopathy(16), 
and Achilles tendon lesions(17,18) have been studied, 
with conflicting results. Few studies have evaluated 
the effect of PRP as an adjuvant to the healing of the 
rotator cuff (RC)(19-24), two of which were prospective 
and randomized(21,22) and two of which were prospec-
tive cohort studies(23,24). Two studies did not show any 
difference between groups(21,23). However, a lower 
index of rerupture(24) and better functional results(22) 
have been evidenced with the use of PRP. The PRP 
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Figure 1 – Haemonetics MCS+ 9000® cell separator and 994-CFE 
apheresis-specific set (Haemonetics Corp., MA, USA).
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preparation and application methodology has also been 
controversial(25), and none of the previously published 
studies evaluated the efficacy of the compound obtained 
by apheresis and applied in its activated form, with the 
addition of thrombin. The objective of this study is to 
evaluate the functional results and the index of rerupture 
for arthroRRC with the use of PRP, and to describe the 
technique for its preparation and application.
MATERIALS AND METHODS
We conducted a prospective case series evaluat-
ing the result of arthroRRC combined with the use 
of PRP in patients with an isolated rupture of the su-
praspinatus tendon with less than 3 cm of retraction. 
The research protocol was approved by the ethics 
committee of the institution, and all patients signed 
an informed consent form. The procedures were per-
formed by the same surgeon and at the same institu-
tion (IOT-HCFMUSP) during the period of September 
2008 to March 2011.
selection of subjects
The inclusion criteria were complete rupture of 
the supraspinatus tendon with less than 3 cm retrac-
tion and lack of rupture of the subscapularis and 
infraspinatus, confirmed by preoperative magnetic 
resonance imaging (preMRI); failure of conservative 
therapy performed for at least three months; fatty de-
generation of RC muscle lower than Goutallier grade 
2; absence of glenohumeral osteoarthritis or rotator 
cuff arthropathy; platelet concentration greater than 
or equal to 150,000/mm3; absence of coagulopathy 
or chronic use of anticoagulants; skeletally mature, 
with no age limits; absence of psychiatric disorders, 
fibromyalgia, painful cervical spine disorders, un-
compensated clinical comorbidities, active or recent 
infection; absence of fractures or previous surgery in 
the affected shoulder.
The exclusion criteria were intraoperative observa-
tion of rupture of the tendon of the subscapularis or 
infraspinatus requiring repair, or supraspinatus tears 
with retraction greater than 3 cm; lesions not amena-
ble to complete repair; patients who did not undergo 
postoperative clinical evaluations.
PrP Collection 
A Haemonetics MCS+ 9000® cell separator and a 
994-CFE apheresis-specific set (Haemonetics Corp., 
MA, USA) were used to prepare the PRP (Figure 1). 
Approximately 400 mL of blood were drained to a 
device for separation under 5800RPM continuous 
centrifugation for 15 minutes through a peripheral 
access. Sodium citrate was used as an anticoagulant at 
a ratio of 1 ml for every 9 ml of blood. In this device, 
after the separation of blood components by density 
gradient, an optical analyzer identified the platelet 
layer by its refraction characteristics and separated it 
into a sterile collection bag, obtaining about 30 ml of 
PRP. The remaining blood was returned to the patient 
by the same venous access, resulting in no loss of the 
other blood components.
Ten milliliters of PRP plus 400 mm3 of 10% cal-
cium chloride were used for the formation of throm-
bin from an autologous source, which was used with 
the activator of the coagulation cascade. After gel 
formed in the sample, the supernatant, which was rich 
in thrombin, was collected.
The material necessary for the subsequent appli-
cation of PRP in its activated form was packaged in 
syringes: two aliquots of PRP (10 mL each) and two 
fractions of thrombin and 10% calcium chloride (1.5 
and 0.8 mL each, respectively) (Figure 2). The entire 
collection procedure was performed after anesthesia.
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Figure 2 – PRP and platelet activators (calcium chloride and thrombin).
Figure 3 – Needle inserted through the skin, after portals are sutured.
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rotator cuff repair
The patients were operated in the beach chair po-
sition under general anesthesia combined with an 
interscalene block. Bursectomy, acromioplasty, and 
coracoacromial ligament release were performed in 
all cases, as well as cruentation of the greater tubercle. 
No patient underwent resection of the distal clavicle.
The tendon of the long head of the biceps was 
approached through tenodesis when it presented 
instability, partial lesions larger than 50% or insertional 
lesions (SLAP lesions) types 3 and 4. Tenodesis was 
performed using one of the more anterior ends of 
the anchor wire used in RCR through a single stitch 
fixing the supraspinatus tendon together with the 
long head of the biceps. The RC was repaired with 
5-mm bioabsorbable anchors doubly loaded with 
high strength wires. Tendon-tendon sutures were 
performed when necessary.
Application of PrP
The technique for applying the PRP was based 
on a study by Randelli et al(20). Upon completion 
of the RCR, suture of the arthroscopic portals was 
performed except the posterior portal, which was 
maintained for visualization. A number 14 long 
needle was then introduced through the skin, and not 
by one of the previously created portals. The position 
of needle insertion was located at a point between 
the anterior and the lateral portals (Figure 3). The 
needle tip was then positioned in the tendon and bone 
interface (Figure 4). The saline infusion was then 
closed and the remaining liquid in the subacromial 
space was aspirated, while maintaining visualization. 
The platelet concentrate was then applied. Each 10 ml 
of PRP collected was mixed with 1.5 ml of autologous 
thrombin and 0.8 ml of 10% calcium chloride and 
injected in liquid form through the previously placed 
needle. During this phase, an assistant obstructed the 
already sutured portals with their fingers to minimize 
leakage of the injected material (Figure 5). Five 
minutes after the application, the assistant ceased to 
block the portals and the posterior portal was sutured 
in the same way as the others.
Figure 4 – Needle positioned between the repaired tendon and the 
bone bed.
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Figure 5 – Assistant manually blocking the already sutured portals while 
the PRP is injected.
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Postoperative care
Immobilization with mesh Velpeau was maintained 
for a total of six weeks, and in the first three weeks no 
movements were performed with the shoulder. Slight 
movements with the elbow, wrist and fingers were 
directed. Light passive exercises were initiated after 
the end of the third week. Free active and active-
assisted exercises were started only after the sixth 
week, with the termination of the use of the sling. 
Muscle strengthening (resistance active exercises) 
was performed only after significant movement gain 
in the 12th week.
VARIABLES ANALyZED
Clinical evaluation
We performed a clinical assessment of patients 
through the Constant-Murley and UCLA functional 
scales, performed preoperatively and 12 months post-
operatively. The pain visual analog scale (VAS) was 
measured in the same periods. Postoperative com-
plications were also evaluated. The evaluations were 
performed by a physiotherapist from the Shoulder 
and Elbow Group of our institution, which did not 
participate in the study.
imaging evaluation
The shape of the acromion (flat, curved or hooked) 
was evaluated in preoperative radiographs in the su-
praspinatus tendon tunnel view. The size of the supra-
spinatus tendon lesion was measured in mm on the 
preMRI. On the postoperative magnetic resonance 
imaging (postMRI) held at 12 months of follow-up, 
whether the RC was intact (complete restoration of 
its insertion), with partial rerupture (thinning of in-
sertion, but without transfixing lesion) or complete 
rerupture (transfixing lesion) was investigated. Mag-
netic resonance imaging (MRI) was evaluated by a 
radiologist specialized in musculoskeletal imaging.
intraoperative assessment
Data on the pattern of the lesion (C, V, or L), the 
number of sutures and anchors used, the appearance 
of the subscapularis tendon (normal or partial rup-
ture), and whether or not tenodesis was performed 
were collected.
statistical analysis
Data normality was tested by the Shapiro-Wilk 
test. The variables were evaluated using the Student’s 
t-test (parametric data) or the Wilcoxon test (non-
parametric data). Parametric data were expressed as 
means and standard deviations; nonparametric data 
as medians and percentiles. Categorical data were put 
forth as percentages. The value of p < 0.05 was con-
sidered statistically significant. We used Stata 10.0.
RESULTS
During the study period, 15 patients underwent the 
procedure (15 shoulders). Of these, one was excluded 
because the patient evolved with ipsilateral hemipa-
resis to the shoulder surgery after resection of a brain 
meningioma. Fourteen patients (14 shoulders), eight 
of whom were females (57.14%), were evaluated. The 
right side was affected in 11 (78.6%). All the cases 
occurred on the dominant side. The mean age was 
51.86 ± 8.72 years.
The pain of the patients showed significant 
improvement according to the VAS (p = 0.0013), 
decreasing from a median of 7.5 (p25% = 6, p75% 
= 8) to 0.5 (p25% = 0, p75% = 3). The comparison 
between pre- and post-surgical scores on the Constant-
Murley and UCLA scales can be seen in Table 1. 
Only one patient developed clinical complication 
(adhesive capsulitis). There were no cases of infection 
or allergic reaction.
A curved acromion occurred in 11 patients (78.6%). 
Hooked and flat acromions were observed in two 
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Figure 6 – MR image. (A) Preoperatively, with complete rupture of the 
supraspinatus. (B) Postoperatively, with no evidence of rerupture (inter-
position of fluid between the tendon and bone is not observed).
A
B
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(14.3%) patients and one (7.1%) patient, respectively.
Regarding the pattern of injury, five (35.7%) 
were “C”, five (35.7%) were “L”, and four (28.6%) 
were “V”. The subscapularis tendon was intact in 12 
(85.7%). In the other two cases, there was a partial 
joint injury that did not require repair. Tenodesis of the 
long head of the biceps was performed in two patients 
(14.3%). In the other cases the biceps was intact.
An anchor was used in 10 patients (71.4%), and 
two anchors were used in four (28.6%). Two patients 
(14.3%) received additional tendon-tendon sutures. 
Most patients (nine cases) had their lesions repaired 
with two stitches (64.3%). Three sutures were re-
quired in one (7.1%), four sutures in three (21.4%) 
and six sutures in one (7.1%) patient.
The lesions were 12.5 ± 4.11 mm in length and had 
15.64 ± 7.26 mm retraction, according to the preMRI.
In the postMRI, no patient had complete supra-
spinatus tendon rerupture. The tendon was presented 
intact in 11 cases (78.6%) (Figure 6). Partial rerupture 
was observed in three patients (21.4%) (Figure 7); in 
two cases it affected about 50% of the thickness of the 
tendon, and 25% in one case. All reruptures affected 
the joint surface of the supraspinatus.
DISCUSSION
The clinical results of this study show a significant 
improvement when comparing the pre- to the posto-
perative evaluations, similar to other publications(2-4). 
Among the comparative studies evaluating the use of 
PRP in arthroRRC, three did not observe any clini-
cal difference between the groups(21,23,24). Randelli
et al.(22), however, note less pain in the first month and 
better evaluations according to the Constant-Murley 
scale at the end of the third month in cases that used 
PRP in their report. Evaluating a subgroup of patients 
with small- and medium-sized tears, they observed 
that those with the addition of PRP performed better 
in all functional scales at the end of the first quar-
ter, and significantly better values for the Constant-
Murley scale at 12 months and external rotational 
strength at three, six, 12 and 24 months.
With respect to structural integrity, we observed 
that all the comparative studies on the effect of PRP 
in arthroRRC(21-24) demonstrated a lower incidence 
of rerupture with the use of platelet concentrate. 
However, only Barber et al(24) observed a statistically 
significant difference between groups. Evaluating only 
isolated ruptures of the supraspinatus smaller than 
3cm, Castricini et al(21) found only one rerupture in 40 
patients (2.5%). Randelli et al.(22) analyzed a subgroup 
of patients with small and medium-sized tears, and 
observed reruptures in 14% of patients. With a less 
homogeneous sample, including extensive ruptures, 
Jo et al(23) and Barber et al(24) identified rerupture rates 
of 26.7 and 30%, respectively. Our study did not show 
any complete reruptures, which was an inferior result 
to studies using PRP(21-24) as well as those that did not 
use PRP(2-6). It is worth noting that we performed the 
Table 1 – Pre- and postoperative values of the functional scales. 
Preoperative Postoperative
Mean SD Mean SD p
Constant-Murley 45.64 12.29 80.78 13.22 < 0.0001
UCLA 13.78 5.66 31.43 3.9 < 0.0001
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Figura 7 – Imagem de RM. (A) Pré-operatório, com rotura completa do 
supraespinal. (B) Pós-operatório, com sinais de rerrotura parcial articular 
(nota-se a interposição de líquido sinovial entre o tendão e o osso medial-
mente à âncora, sem descontinuidade do folheto bursal).
A
B
MRI at 12 months postoperatively, a time earlier than 
that of other publications(2,5,21,22). Furthermore, we 
evaluated only isolated lesions of the supraspinatus 
with less than 3 cm retraction, unlike other authors, 
who have included large and extensive ruptures in 
their evaluations(2,4,5,23,24).
There is great heterogeneity in the methods of 
obtaining PRP described in literature, and they are 
divided into two groups: apheresis(26) and centrifuga-
tion(27). The apheresis method employed in this study 
presents higher platelet levels and lower leukocyte 
concentrations(28), as the PRP obtained in this manner 
is considered more pure(25). Centrifugation, currently 
used by most companies, has the advantages of hav-
ing a lower cost and requiring simpler materials(27). 
Among the arthroRRC studies, only Jo et al(23) used 
PRP obtained by apheresis.
The manner of applying the PRP varies between 
studies. We used concentrated liquid form, as described 
by Randelli et al(20) and subsequently used by Randelli 
et al(22) in their clinical trial. Other authors, however, 
use the PRP in gel form, and push it along the anchor 
wires prior to suturing(21,23,24). We believe that this 
method can lead to loss of GF and parts of the clot, as 
it is performed with saline infusion, unlike the form 
used by us, in which the application is performed 
after closing the infusion, at the end of the procedure. 
Among the advantages of the application in a solid 
consistency, we can cite the fact that the PRP can 
conceivably be placed effectively between the 
tendon and bone, unlike what occurs with the liquid 
consistency, in which the PRP spreads through the 
subacromial space, even when positioning the needle 
at the tendon-bone interface.
Another source of confusion and heterogeneity 
between the studies is the application of concentrate 
that is activated or not. In our study, we use the PRP 
that has been activated by the addition of thrombin and 
calcium chloride. Mazzucco et al(29) and Han et al(30) 
describe that the activation of PRP with thrombin leads 
to an immediate release of GF, and that a slower and 
more prolonged release could increase the beneficial 
effects of PRP. Moreover, Virchenko et al(31) show 
that the use of thrombin increases the effectiveness of 
PRP in tendon repair. Only two studies(20,22) have used 
thrombin, and the other authors have applied non-
activated PRP(21,23,24). Our study is unique in that it 
evaluates the use of PRP in arthroRRC using material 
obtained by apheresis and applied with the addition 
of thrombin.
A Haemonetics MCS+ 9000® cell separator and a 
994-CFE apheresis-specific set (Haemonetics Corp., 
MA, USA) were used to prepare the PRP. This same 
method was used in two other studies performed at 
our institution(13,14), and has proven to be effective in 
obtaining high platelet concentrations. O’Neil(32) and 
de Almeida et al(14) observed an average concentration 
of 1,420,000 and 1,185,166 platelets/mm3, respec-
tively. Thus, we chose not to measure the number of 
platelets in our study.
We can cite the small sample, clinical follow-up 
of only 12 months, and a non-comparative design 
as the main limitations of the study. A prospective 
randomized clinical trial is currently being conducted 
at our institution, with which we hope to get more 
consistent answers about the real effectiveness 
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of the method. Clinical and MRI evaluation in all 
patients at the end of the follow-up time conducted 
in a standardized way are favorable points, besides 
addressing a homogeneous sample, with strict 
inclusion criteria.
CONCLUSION
Patients undergoing arthroRRC associated with the 
use of PRP showed a significant functional improve-
ment and no cases of complete rerupture.
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